Document is current
Any future updates will be listed below
-
Authors
Moyano-Gómez, Paola
Lehtonen, Jukka V.
Pentikäinen, Olli T.
Postila, Pekka A.
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden,Denmark (0075825, 0075825, 0075825)
Novo Nordisk Fonden (0068926)
Academy of Finland,Finland (337530)
- License Information
-
More Information
Article History
Received: 5 October 2023
Accepted: 12 May 2024
First Online: 9 August 2024
Declarations
:
: O.T.P. is a founder and shareholder of Aurlide Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
